Sign in
EBACU Stock Price, Chart, Stats & News
European Biotech Acquisition Corp.
Save
European Biotech Acquisition Corp. (EBACU) does not currently pay a dividend.
181.22M
Market cap
82.48x
Current P/E
–
Forward P/E
EBACU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -921.86% |
ROA | 2.70% |
ROE | 2.90% |
D/E | – |
Interest coverage ratio | – |
EBACU valuation
P/E | 82.48x |
P/S | – |
P/B | 1.18x |
P/CF | -277.25x |
P/FCF | -356.46x |
P/OCF | -277.25x |
PEG | 0.41x |
EV multiple | -65.23x |
About
European Biotech Acquisition Corp. currently lacks substantial business activities. Its primary objective is to complete a strategic business combination, such as a merger, stock swap, asset takeover, equity purchase, or corporate restructuring, involving one or multiple enterprises. Established in 2021, the entity's headquarters are located in Amsterdam, Netherlands.
Similar securities
Based on sector and market capitalization
Report issue